- Session: Shielding for Nuc Med PETCT and Radiopharmaceutical Therapy
Tweet #link
This video is currently visible only to AAPM Members, Affiliates and Developing Country Educational Associates. Embargo periods are typically one year from the date the presentation was first published.
![]() |
Shielding for Nuc Med PETCT and Radiopharmaceutical Therapy Pooley Robert, PhD, Mayo Clinic |
Graph includes member loads and non-member loads (0 total loads). Exclude non-member? A load is defined as someone coming to this page, not necesarily that they pressed play, or watched the entire presentation.




















